Category: 5. Biology

Continue Reading

  • TNF and type I interferon crosstalk controls the fate and function of plasmacytoid dendritic cells

    TNF and type I interferon crosstalk controls the fate and function of plasmacytoid dendritic cells

    Plasmacytoid DCs convert into cDC2s on activation

    We hypothesized that single-cell multiomics would allow us to track the fate of individual pDCs during activation. To establish a reference framework, we first generated a panDC map capturing the…

    Continue Reading

  • Morphological profiling reveals neuroprotection via mitochondrial uncoupling in human dopaminergic neurons

    Morphological profiling reveals neuroprotection via mitochondrial uncoupling in human dopaminergic neurons

    Origin of iPSC lines and differentiation into mDA neurons

    SNCA iPSC lines (originally named AST23 and AST23-2KO) were provided and generated by Dr. Tilo Kunath from The University of Edinburgh. The parental cell line AST23 was first described in…

    Continue Reading

  • A unique p52 NF-κB–ETS1 interaction ushers in a new paradigm of germinal center responses

    A unique p52 NF-κB–ETS1 interaction ushers in a new paradigm of germinal center responses

    A unique p52 NF-κB–ETS1 interaction ushers in a new paradigm of germinal center responses

    Continue Reading

  • Cathepsin D promotes acute myeloid leukemia progression through stabilization of the anti-apoptotic proteins

    Cathepsin D promotes acute myeloid leukemia progression through stabilization of the anti-apoptotic proteins

    Cell lines

    Human leukemia cell lines HL60, Kasumi, U937, and MV4-11 were purchased from National Collection of Authenticated Cell Cultures (Shanghai, China). Human leukemia KG1 cells was purchased from ATCC (Manassas, Maryland, USA). OCI-AML3 and…

    Continue Reading

  • The brain drain puts aging myelin in deep trouble

    The brain drain puts aging myelin in deep trouble

    The brain drain puts aging myelin in deep trouble

    Continue Reading

  • Response to ‘The puzzle of biologics manufacturing platform patents’

    Amgen is the leading manufacturer of both innovative biologics and biosimilar medicines and is uniquely positioned to respond to the “puzzle” of unsupported assertions in the March Patent Feature by Jefferson et al.1. Contrary to their…

    Continue Reading

  • Correction: TIGIT antibody with PVR competitive ability enhances cancer immunotherapy and capable of eliciting anti-tumour immune memory

    Cite this article

    Yu, H., Jin, S., Zeng, M. et al. Correction: TIGIT antibody with PVR competitive ability enhances cancer immunotherapy and capable of eliciting anti-tumour immune memory.
    Br J Cancer (2025)….

    Continue Reading